Patanjali Ayurved has made $120 billion in sales in the previous financial year and is now looking at new ventures and expanding its business abroad, reported Business Standard.

The company, which has recently entered telecom, security services and mobile applications segments, has worked out on a plan to expand overseas as soon as possible, the report said.

The Patanjali has already secured approval from the US Food and Drug Administration and will start exporting by March 2019, the daily said, adding that the company is also looking to set up manufacturing units in Nepal and Bangladesh.